Health Authorities' Decisions Facilitate Access to the Benefits of the CyberKnife Radiosurgical Technology for Both Medical Practitioners and Patients SUNNYVALE, Calif., April 23, 2010 /PRNewswire via COMTEX/ --Accuray Incorporated, a global leader in the field of radiosurgery, announced today that
New Research Supports CyberKnife(R) Treatment's Long-Term Outcomes for Lung Cancer Patients SUNNYVALE, Calif., and SAN DIEGO, Jan. 31, 2011 /PRNewswire via COMTEX/ -- The Society of Thoracic Surgeons (STS) Annual Meeting - Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
More Than 5,000 Lung Cancer Patients Treated With CyberKnife System to Date SUNNYVALE, Calif., March 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that approximately 90 percent of CyberKnife centers worldwide are now
--Accuray to Present CyberKnife Capabilities at Leading Urology Annual Meeting SUNNYVALE, Calif., April 23, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 3,000 prostate cancer patients have
More than 500 Healthcare Specialists to Convene in Arizona to Share Expertise SUNNYVALE, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 500 medical, clinical and technical specialists have
Success of Non-Invasive Procedure Chronicled in the Journal Spine SUNNYVALE, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced clinical data that shows use of its CyberKnife(R) Robotic Radiosurgery System in the
Full Body Radiosurgery Expands Treatment Options for Patients with Lung, Prostate, Liver and Pancreatic Cancer SUNNYVALE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that treatments of extracranial
Accuray Enters Licensing Agreement with CyberHeart Incorporated SUNNYVALE, Calif., April 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that it has entered into an agreement with CyberHeart Incorporated under which
SUNNYVALE, Calif. , Oct. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO),
Large Scale Study Results Presented in Prostate, Lung and Brain Tumor Treatment SUNNYVALE, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced key clinical presentation highlights from the 7th Annual CyberKnife
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
